XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer
Clinical trial NCT04622072 · TERMINATED
Trial details
- NCT number
- NCT04622072
- Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2021-05-20
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.